Setipiprant
N/A
Report date: 2023/05/23 16:49:18
NME
Base Information
Drug NameSetipiprant
Drug Alias Name +[7]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[13]
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKythera
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesKythera Biopharmaceuticals IncAllergan PlcIdorsia Pharmaceuticals Ltd
Active IndicationsN/A
Inactive Indications